comparemela.com

Latest Breaking News On - Brussels stock exchange argx - Page 1 : comparemela.com

argenx Announces Approval of VYVGART (efgartigimod alfa) in

VYVGART® now approved in Japan for both generalized myasthenia gravis and primary immune thrombocytopenia (ITP) Regulatory decision in Japan represents.

United kingdomUnited statesNoord hollandLuc truyenTim van hauwermeirenBen petokImmunology innovation programInternational working groupJapan ministry of healthDrug administrationChief executive officerChief medical officerPrescribing informationImportant safetyBrussels stock exchange argxArgenx se

argenx Announces European Commission Approval of

VYVGART® is now approved for both intravenous (IV) and self-administered subcutaneous (SC) use in Europe argenx is committed to continued collaboration.

Noord hollandUnited kingdomUnited statesBen petokAnant murthyImmunology innovation programEuropean union eu member statesEuropean commissionCommittee for medicinal products human useMember statesGeneral managerMedicinal productsHuman useNorth americaBrussels stock exchange argxArgenx se

argenx to Report Third Quarter 2023 Financial Results and

October 24, 2023Amsterdam, the Netherlands – argenx (Euronext & Nasdaq: ARGX), a global immunology company committed to improving the lives of people.

United kingdomNoord hollandUnited statesErin murphyImmunology innovation programBrussels stock exchange argxArgenx se

argenx Announces Positive CHMP Opinion for Subcutaneous

Positive opinion based on Phase 3 ADAPT-SC study demonstrating noninferior total IgG reduction at day 29 with subcutaneously (SC) administered.

Noord hollandUnited statesUnited kingdomErin murphyAnant murthyEuropean commissionGhent university hospitalCommittee for medicinal products human useGhent universityImmunology innovation programEuropean medicines agencyEuropean union member statesMedicinal productsHuman useGeneral managerUnion member states

argenx raises $1 1 billion in gross proceeds in a global

Regulated information Inside information July 18, 2023, 9:20 PM ET July 19, 2023, 3:20 AM CET Amsterdam, the Netherlands argenx SE.

United kingdomUnited statesNorth carolinaNoord hollandNew yorkVan lanschot kempenErin murphyGoldman sachs coEuropean supervisory authorityAuthority autoriteit financiJp morgan securitiesBelgian financial servicesBroadridge financial solutionsMorgan stanleyEuropean union withdrawalExchange commission

vimarsana © 2020. All Rights Reserved.